Literature DB >> 18385237

Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes.

Peter Pelka1, Jailal N G Ablack, Gregory J Fonseca, Ahmed F Yousef, Joe S Mymryk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18385237      PMCID： PMC2493305          DOI： 10.1128/JVI.00104-08

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  149 in total

1.  BS69, an adenovirus E1A-associated protein, inhibits the transcriptional activity of c-Myb.

Authors:  N E Ladendorff; S Wu; J S Lipsick
Journal:  Oncogene       Date:  2001-01-04       Impact factor: 9.867

2.  RACK1 interacts with E1A and rescues E1A-induced yeast growth inhibition and mammalian cell apoptosis.

Authors:  N Sang; A Severino; P Russo; A Baldi; A Giordano; A M Mileo; M G Paggi; A De Luca
Journal:  J Biol Chem       Date:  2001-05-17       Impact factor: 5.157

Review 3.  Flexible nets. The roles of intrinsic disorder in protein interaction networks.

Authors:  A Keith Dunker; Marc S Cortese; Pedro Romero; Lilia M Iakoucheva; Vladimir N Uversky
Journal:  FEBS J       Date:  2005-10       Impact factor: 5.542

4.  Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2.

Authors:  K Somasundaram; G Jayaraman; T Williams; E Moran; S Frisch; B Thimmapaya
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

5.  Interaction of the E1A oncoprotein with Yak1p, a novel regulator of yeast pseudohyphal differentiation, and related mammalian kinases.

Authors:  Z Zhang; M M Smith; J S Mymryk
Journal:  Mol Biol Cell       Date:  2001-03       Impact factor: 4.138

6.  An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy.

Authors:  C Heise; T Hermiston; L Johnson; G Brooks; A Sampson-Johannes; A Williams; L Hawkins; D Kirn
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

7.  Sequences in E1A proteins of human adenovirus 5 required for cell transformation, repression of a transcriptional enhancer, and induction of proliferating cell nuclear antigen.

Authors:  T N Jelsma; J A Howe; J S Mymryk; C M Evelegh; N F Cunniff; S T Bayley
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

8.  The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A.

Authors:  W C Phelps; C L Yee; K Münger; P M Howley
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

9.  Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation.

Authors:  S Mittnacht; J A Lees; D Desai; E Harlow; D O Morgan; R A Weinberg
Journal:  EMBO J       Date:  1994-01-01       Impact factor: 11.598

10.  Differential splicing yields novel adenovirus 5 E1A mRNAs that encode 30 kd and 35 kd proteins.

Authors:  C Stephens; E Harlow
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598
View more
  79 in total

1.  Transformation by E1A oncoprotein involves ubiquitin-mediated proteolysis of the neuronal and tumor repressor REST in the nucleus.

Authors:  Hancheng Guan; Robert P Ricciardi
Journal:  J Virol       Date:  2012-03-14       Impact factor: 5.103

2.  Cellular GCN5 is a novel regulator of human adenovirus E1A-conserved region 3 transactivation.

Authors:  Jailal N G Ablack; Michael Cohen; Gobi Thillainadesan; Gregory J Fonseca; Peter Pelka; Joe Torchia; Joe S Mymryk
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  The N terminus of adenovirus type 12 E1A inhibits major histocompatibility complex class I expression by preventing phosphorylation of NF-kappaB p65 Ser276 through direct binding.

Authors:  Junfang Jiao; Hancheng Guan; Andrew M Lippa; Robert P Ricciardi
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

4.  The Dual Nature of Nek9 in Adenovirus Replication.

Authors:  Richard Jung; Sandi Radko; Peter Pelka
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

Review 5.  Viral and cellular interactions during adenovirus DNA replication.

Authors:  Matthew Charman; Christin Herrmann; Matthew D Weitzman
Journal:  FEBS Lett       Date:  2019-12-17       Impact factor: 4.124

Review 6.  Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation.

Authors:  Andrew N Blackford; Roger J A Grand
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

7.  Contamination with E1A-positive wild-type adenovirus accounts for species-specific stimulation of islet cell proliferation by CCK: a cautionary note.

Authors:  Jeremy A Lavine; Philipp W Raess; Dawn B Davis; Mary E Rabaglia; Brent K Presley; Mark P Keller; Margery C Beinfeld; Alan S Kopin; Christopher B Newgard; Alan D Attie
Journal:  Mol Endocrinol       Date:  2010-01-15

8.  Ad E1A 243R oncoprotein promotes association of proto-oncogene product MYC with the NuA4/Tip60 complex via the E1A N-terminal repression domain.

Authors:  Ling-Jun Zhao; Paul M Loewenstein; Maurice Green
Journal:  Virology       Date:  2016-09-22       Impact factor: 3.616

9.  Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1/K2 transcription factors.

Authors:  Jessica Komorek; Mohan Kuppuswamy; T Subramanian; S Vijayalingam; Elena Lomonosova; Ling-Jun Zhao; Joe S Mymryk; Kimberly Schmitt; G Chinnadurai
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

10.  A structural basis for the assembly and functions of a viral polymer that inactivates multiple tumor suppressors.

Authors:  Horng D Ou; Witek Kwiatkowski; Thomas J Deerinck; Andrew Noske; Katie Y Blain; Hannah S Land; Conrado Soria; Colin J Powers; Andrew P May; Xiaokun Shu; Roger Y Tsien; James A J Fitzpatrick; Jeff A Long; Mark H Ellisman; Senyon Choe; Clodagh C O'Shea
Journal:  Cell       Date:  2012-10-12       Impact factor: 41.582
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.